The AOAC Research Institute, the approval body for all U.S. food safety tests, has certified Vacci-Test’s FoodChek(TM)-E.Coli as a Performance Tested(SM) method for detecting E.coli O157 in raw ground beef. This extremely rapid and accurate new test is seen as a technological breakthrough for meat-processors. This approval clears the way for FoodChek(TM)-E.Coli to be sold as a certified food safety test in the United States and internationally.
Fifty times more sensitive than PCR methods, FoodChek(TM)-E.Coli is revolutionizing the industry and setting the new standard for accuracy and speed in food safety testing. By utilizing magnetic nanotechnology and an inexpensive easy-to-use magnetic reader, FoodChek(TM)-E.coli provides the most sensitive and quantitative result in a fraction of the time required by conventional testing.
Dr. Richard J. Flanagan, Chief Scientific Officer, said “We have now received confirmation that our state-of-the-art technology can easily be implemented in routine food safety testing. We also know that its extraordinary sensitivity will provide highly accurate results in much shorter testing times, enabling meat-processors to quickly and confidently release products into the marketplace with less likelihood of product recalls.”
ABOUT AOAC
The AOAC Research Institute, a subsidiary of AOAC International (www.aoac.org), is an independent non-profit corporation whose stated purpose is to promote and carry out activities related to the development, improvement, and understanding of analytical practices and procedures affecting public health and welfare.
ABOUT VACCI-TEST
Vacci-Test is a privately held Canadian corporation based in Calgary, Alberta that specializes in the development and commercialization of proprietary food safety tests, based on magnetic nanotechnology, for the rapid, accurate detection and quantitative measurement of pathogens in food.
This information release may contain certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company’s current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its private filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contacts: Vacci-Test Corporation Richard Flanagan Ph.D. Chief Scientific Officer (403) 269-9424 ?Vacci-Test Corporation William J. Hogan Vice Chairman (403) 269-9424 ?Vacci-Test Corporation Suite 1005, 550 - 11th Avenue S.W. Calgary, Alberta, Canada T2R 1M7 Email: info@vaccitest.com Website: www.vaccitest.com ?
